Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Straus

Showing results (171-180 of 215) with videos related to

Pageof 22
Sort By:
Alternatives to Laboratory Animals : ATLA|June 5, 2015
Issues relating to the release of proprietary information and data for use in the validation of alternative methodsM Todd, B Garthoff, W Bernhardt, et al.
British Journal of Clinical Pharmacology|December 4, 2014
Understanding drug preferences, different perspectivesPeter G M Mol, Arna H Arnardottir, Sabine M J Straus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2009
Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experienceS M Edwards-Bennett, L M Jacks, C H Moskowitz, et al.
Bone Marrow Transplantation|April 27, 1999
The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphomaC H Moskowitz, S D Nimer, J R Glassman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
Semen cryopreservation and artificial insemination for Hodgkin's diseaseJ R Redman, D R Bajorunas, M C Goldstein, et al.
The New England Journal of Medicine|June 5, 1997
Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials GroupL D Kaplan, D J Straus, M A Testa, et al.
Blood|April 5, 2003
Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphomaPaul A Hamlin, Andrew D Zelenetz, Tarun Kewalramani, et al.
Leukemia & Lymphoma|March 17, 2012
Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?Lale Kostakoglu, Heiko Schöder, Jeffrey L Johnson, et al.
Medicine|November 1, 1980
The acute monocytic leukemias: multidisciplinary studies in 45 patientsD J Straus, R Mertelsmann, B Koziner, et al.
Haematologica|October 5, 2023
Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1Howland E Crosswell, Ann S LaCasce, Nancy L Bartlett, et al.
Pageof 22

Showing results (171-180 of 215) with videos related to

Sort By:
Pageof 22
Alternatives to Laboratory Animals : ATLA|June 5, 2015
Issues relating to the release of proprietary information and data for use in the validation of alternative methodsM Todd, B Garthoff, W Bernhardt, et al.
British Journal of Clinical Pharmacology|December 4, 2014
Understanding drug preferences, different perspectivesPeter G M Mol, Arna H Arnardottir, Sabine M J Straus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2009
Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experienceS M Edwards-Bennett, L M Jacks, C H Moskowitz, et al.
Bone Marrow Transplantation|April 27, 1999
The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphomaC H Moskowitz, S D Nimer, J R Glassman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
Semen cryopreservation and artificial insemination for Hodgkin's diseaseJ R Redman, D R Bajorunas, M C Goldstein, et al.
The New England Journal of Medicine|June 5, 1997
Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials GroupL D Kaplan, D J Straus, M A Testa, et al.
Blood|April 5, 2003
Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphomaPaul A Hamlin, Andrew D Zelenetz, Tarun Kewalramani, et al.
Leukemia & Lymphoma|March 17, 2012
Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?Lale Kostakoglu, Heiko Schöder, Jeffrey L Johnson, et al.
Medicine|November 1, 1980
The acute monocytic leukemias: multidisciplinary studies in 45 patientsD J Straus, R Mertelsmann, B Koziner, et al.
Haematologica|October 5, 2023
Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1Howland E Crosswell, Ann S LaCasce, Nancy L Bartlett, et al.
Pageof 22